Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study, Expert Opinion on Drug Delivery, December 2017, Taylor & Francis,
DOI: 10.1080/17425247.2018.1407755.
You can read the full text:
Contributors
The following have contributed to this page
